Human cartilage gp-39, CD16+ monocytes in peripheral blood and synovium: Correlation with joint destruction in rheumatoid arthritis

Arthritis and Rheumatism

Volumn 43, Issue 6, 2000, Pages 1233-1243

  Baeten, Dominique ^a   Boots, Annemieke M H ^b   Steenbakkers, Peter G A ^b   Elewaut, Dirk ^a   Bos, Ebo ^b   Verheijden, Gijs F M ^b   Verbruggen, Gust ^a   Miltenburg, André M M ^b   Rijnders, Antonius W M ^b   Veys, Eric M ^a   De Keyser, Filip ^a  

^a GHENT UNIVERSITY HOSPITAL   (Belgium)

^b NV ORGANON   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CD14 ANTIGEN; CD16 ANTIGEN; GLYCOPROTEIN GP 39;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; MALE; MONOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RHEUMATOID ARTHRITIS; SPONDYLOARTHROPATHY; SYNOVIUM;

ADULT; AGED; ANTIGENS, CD; ARTHRITIS, RHEUMATOID; CARTILAGE, ARTICULAR; CELL DIFFERENTIATION; CELLS, CULTURED; FEMALE; GLYCOPROTEINS; HUMANS; MALE; MIDDLE AGED; MONOCYTES; PHENOTYPE; SYNOVIAL MEMBRANE;

EID: 0034123291     PISSN: 00043591     EISSN: None     Source Type: Journal    
DOI: 10.1002/1529-0131(200006)43:6<1233::AID-ANR6>3.0.CO;2-9     Document Type: Article

References (31)

1. Nyirkos P, Golds EE. Human synovial cells secrete a 39kDa protein similar to a bovine mammary protein expressed during the non-lactating period. Biochem J 1990;268:265-8.
2. Johansen JS, Williamson MK, Rice JS, Price PA. Identification of proteins secreted by human osteoblastic cells in culture. J Bone Miner Res 1992;7:501-12.
3. Hakala BE, White C, Recklies AD. Human cartilage gp-39, a major secretory product of articular chondrocytes and synovial cells, is a mammalian member of a chitinase protein family. J Biol Chem 1993;268:25803-10.
4. Verhage HG, Mavrogianis PA, O'Day-Bowman MB, Schmidt A, Arias EB, Donnelly KM, et al. Characteristics of an oviductal glycoprotein and its potential role in the fertilization process. Biol Reprod 1998;58:1098-101.
5. Hu B, Trinh K, Figucira WF, Price PA. Isolation and sequence of a novel human chondrocyte protein related to mammalian members of the chitinase protein family. J Biol Chem 1996;271: 19415-20.
6. Renkema GH, Boot RG, Muijsers AO, Donker-Koopman WE, Aerts JM. Purification and characterization of human chitotriosidase, a novel member of the chitinase family of proteins. J Biol Chem 1995;270:2198-202.
7. Johansen JS, Cintin C, Jørgensen M, Kamby C, Price PA. Serum YKL-40: a new potential marker of prognosis and location of metastases of patients with recurrent breast cancer. Eur J Cancer 1995;31A:1437-42.
8. Johansen JS, Møller S, Price PA, Bendtsen F, Junge J, Garbarsch C, et al. Plasma YKL-40: a new potential marker of fibrosis in patients with alcoholic cirrhosis? Scand J Gastroenterol 1997;32: 582-90.
9. Verheijden GFM, Rijnders AWM, Bos E, Coenen-de Roo CJJ, van Staveren CJ, Miltenburg AMM, et al. Human cartilage glycoprotein-39 as a candidate autoantigen in rheumatoid arthritis. Arthritis Rheum 1997;40:1115-25.
10. Johansen JS, Jensen HS, Price PA. A new biochemical marker for joint injury: analysis of YKL-40 in serum and synovial fluid. Br J Rheumatol 1993;32:949-55.
11. Johansen JS, Hansen M, Stoltenberg M, Florescu A, Price PA, Hørslev-Petersen K, et al. Serum YKL-40 reflects disease activity in patients with rheumatoid arthritis [abstract]. Arthritis Rheum 1997;40 Suppl 9:S149.
12. Joosten LAB, Coenen-de Roo CJJ, Helsen MMA, Lubberts E, Boots AMH, van den Berg WB, et al. Induction of tolerance with intranasal administration of human cartilage gp-39 in DBA/1 mice: amelioration of clinical, histologic, and radiologic signs of type II collagen-induced arthritis. Arthritis Rheum 2000;43:645-55.
13. Volck B, Price PA, Johansen JS, Sorensen O, Benfield TL, Nielsen HJ, et al. YKL-40, a mammalian member of the chitinase family, is a matrix protein of specific granules in human neutrophils. Proc Assoc Am Physicians 1998;110:351-60.
14. Krause SW, Rehli M, Kreutz M, Schwarzfischer L, Paulauskis JD, Andreesen R. Differential screening identifies genetic markers of monocyte to macrophage maturation. J Leukoc Biol 1996;60: 540-5.
15. Kirkpatrick RB, Emery JG, Connor JR, Dodds R, Lysko PG, Rosenberg M. Induction and expression of human cartilage glycoprotein 39 in rheumatoid inflammatory and peripheral blood monocyte-derived macrophages. Exp Cell Res 1997;237:46-54.
16. Volck B, Johansen JS, Østergaard M, Stoltenberg M, Løvgreen P, Price PA, et al. Serum and synovial fluid levels of YKL-40 in relation to synovial inflammation in patients with rheumatoid arthritis and osteoarthritis [abstract]. Arthritis Rheum 1997;40 Suppl 9:S248.
17. Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988;31:315-24.
18. Steinbrocker O, Traeger CH, Batterman RC. Therapeutic criteria in rheumatoid arthritis. JAMA 1949;140:659-62.
19. Smeets TJM, Dolhain RJEM, Breedveld FC, Tak PP. Analysis of the cellular infiltrates and expression of cytokines in synovial tissue from patients with rheumatoid arthritis and reactive arthritis. J Pathol 1998;186:75-81.
20. Johansen JS, Hvolris J, Hansen M, Backer V, Lorenzen I, Price PA. Serum YKL-40 levels in healthy children and adults: comparison with serum and synovial fluid levels of YKL-40 in patients with osteoarthritis or trauma of the knee joint. Br J Rheumatol 1996;35:553-9.
21. Thomas R, Lipsky P. Human peripheral blood dendritic cell subsets: isolation and characterization of precursors and mature antigen-presenting cells. J Immunol 1994;153:4016-28.
22. Ziegler-Heitbrock HWL. Heterogeneity of human blood monocytes: the CD14+ CD16+ subpopulation. Immunol Today 1996; 17:424-8.
23. Ziegler-Heitbrock HWL, Fingerlc G, Ströbel M, Schraut W, Stelter F, Schütt C, et al. The novel subset of CD14+/CD16+ blood monocytes exhibits features of tissue macrophages. Eur J Immunol 1993;23:2053-8.
24. Passlick B, Flieger D, Ziegler-Heitbrock HWL. Identification and characterization of a novel monocyte subpopulation in human peripheral blood. Blood 1989;74:2527-34.
25. Fingerle G, Pforte A, Blumenstein M, Ströbel M, Ziegler-Heitbrock HWL The novel subset of CD14+/CD16+ blood monocytes is expanded in sepsis patients. Blood 1993;82:3170-6.
26. Saleh MN, Goldman SJ, LoBuglio AF, Beall AC, Sabio H, McCord MC, et al. CD16+ monocytes in patients with cancer: spontaneous elevation and pharmacologic induction by recombinant human macrophage colony-stimulating factor. Blood 1995; 85:2910-7.
27. Munn DH, Bree AG, Beall AC, Kaviani MD, Sabio H, Schaub RG. Recombinant human macrophage colony-stimulating factor in non human primates: selective expansion of a CD16+ monocyte subset with phenotypic similarity to primate natural killer cells. Blood 1996;88:1215-24.
28. Edwards JCW, Blades S, Cambridge G. Restricted expression of FcγRIII (CD16) in synovium and dermis: implications for tissue targeting in rheumatoid arthritis. Clin Exp Immunol 1997;108: 401-6.
29. Bhatia A, Blades S, Cambridge J, Edwards JCW. Systematic analysis of normal tissues confirms that macrophages only carry IgG Fc receptor FcγRIIIa in tissues targeted by rheumatoid arthritis [abstract]. Arthritis Rheum 1998;41 Suppl 9:S319.
30. Mulherin D, FitzGerald O, Bresnihan B. Synovial tissue macrophage populations and articular damage in rheumatoid arthritis. Arthritis Rheum 1996;39:115-24.
31. Yanni G, Whelan A, Feighery C, Bresnihan B. Synovial tissue macrophages and joint erosion in rheumatoid arthritis. Ann Rheum Dis 1994;53:39-44.